From the Cover
Are Drug Prices Abroad Too Low?
Countries’ contributions to the pharmaceutical R&D public good reflect the size of their economies.
Features
What Should Become of US Steel?
Policymakers have little reason to fear the Nippon Steel deal.
Assessing Trump’s New Tariff Ideas
The former president still suffers from “Trade Derangement Syndrome.”
Taking the REINS of the Administrative State
Idaho offers useful insights into the effects of legislative review of regulation.
What Happens Post-Chevron?
What Happens Post-Chevron? — Introduction
Many dire predictions and a lot of heated rhetoric have followed the Loper Bright decision, but what are its likely consequences?
The Game Continues
The Supreme Court’s Loper Bright decision will only change the processes in this game.
Whither Congress?
Aside from creating uncertainty, Loper Bright will likely increase the number of judicial challenges as well as judicial invalidation of rules.
Short-Term vs. Long-Term Effects
As the bureaucratic literature often observes, mission is very important in the motivational structure of public servants.
What’s Next after Loper Bright?
The regulatory problems that emerged both before and after the Chevron decision are much more fundamental and can be traced back to the authorizing statutes, not just the behavior of the administrative state.
In Review
Working Papers
A summary of recent papers that may be of interest to Regulation’s readers.
Final Word
The Weirdness of Politics
Last month, Democrats trotted out a word to chastise this sort of policy flimflam: “Weird.”
